BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 23478574)

  • 1. Egr-1 enhances drug resistance of breast cancer by modulating MDR1 expression in a GGPPS-independent manner.
    Tao W; Shi JF; Zhang Q; Xue B; Sun YJ; Li CJ
    Biomed Pharmacother; 2013 Apr; 67(3):197-202. PubMed ID: 23478574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel.
    Fujita T; Ito K; Izumi H; Kimura M; Sano M; Nakagomi H; Maeno K; Hama Y; Shingu K; Tsuchiya S; Kohno K; Fujimori M
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8837-44. PubMed ID: 16361573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanism of suppression of MDR1 by puerarin from Pueraria lobata via NF-kappaB pathway and cAMP-responsive element transcriptional activity-dependent up-regulation of AMP-activated protein kinase in breast cancer MCF-7/adr cells.
    Hien TT; Kim HG; Han EH; Kang KW; Jeong HG
    Mol Nutr Food Res; 2010 Jul; 54(7):918-28. PubMed ID: 20077420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of P-glycoprotein-mediated multidrug resistance is induced by mollugin in MCF-7/adriamycin cells.
    Tran TP; Kim HG; Choi JH; Na MK; Jeong HG
    Phytomedicine; 2013 May; 20(7):622-31. PubMed ID: 23466342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ETS1 promotes chemoresistance and invasion of paclitaxel-resistant, hormone-refractory PC3 prostate cancer cells by up-regulating MDR1 and MMP9 expression.
    Kato T; Fujita Y; Nakane K; Kojima T; Nozawa Y; Deguchi T; Ito M
    Biochem Biophys Res Commun; 2012 Jan; 417(3):966-71. PubMed ID: 22206665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs.
    Gouazé V; Liu YY; Prickett CS; Yu JY; Giuliano AE; Cabot MC
    Cancer Res; 2005 May; 65(9):3861-7. PubMed ID: 15867385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
    Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible?
    Ratnasinghe D; Daschner PJ; Anver MR; Kasprzak BH; Taylor PR; Yeh GC; Tangrea JA
    Anticancer Res; 2001; 21(3C):2141-7. PubMed ID: 11501838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An early response transcription factor, Egr-1, enhances insulin resistance in type 2 diabetes with chronic hyperinsulinism.
    Shen N; Yu X; Pan FY; Gao X; Xue B; Li CJ
    J Biol Chem; 2011 Apr; 286(16):14508-15. PubMed ID: 21321112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients.
    Cowan KH; Moscow JA; Huang H; Zujewski JA; O'Shaughnessy J; Sorrentino B; Hines K; Carter C; Schneider E; Cusack G; Noone M; Dunbar C; Steinberg S; Wilson W; Goldspiel B; Read EJ; Leitman SF; McDonagh K; Chow C; Abati A; Chiang Y; Chang YN; Gottesman MM; Pastan I; Nienhuis A
    Clin Cancer Res; 1999 Jul; 5(7):1619-28. PubMed ID: 10430060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin.
    Mechetner E; Kyshtoobayeva A; Zonis S; Kim H; Stroup R; Garcia R; Parker RJ; Fruehauf JP
    Clin Cancer Res; 1998 Feb; 4(2):389-98. PubMed ID: 9516927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming paclitaxel resistance in uterine endometrial cancer using a COX-2 inhibitor.
    Hasegawa K; Ishikawa K; Kawai S; Torii Y; Kawamura K; Kato R; Tsukada K; Udagawa Y
    Oncol Rep; 2013 Dec; 30(6):2937-44. PubMed ID: 24100466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of multidrug resistance gene expression in human breast cancer cells by (-)-gossypol-enriched cottonseed oil.
    Ye W; Chang HL; Wang LS; Huang YW; Shu S; Dowd MK; Wan PJ; Sugimoto Y; Lin YC
    Anticancer Res; 2007; 27(1A):107-16. PubMed ID: 17352222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistant breast cancer cells overexpress ETS1 gene.
    Kars MD; Işeri OD; Gündüz U
    Biomed Pharmacother; 2010 Sep; 64(7):458-62. PubMed ID: 20392592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SH003 enhances paclitaxel chemosensitivity in MCF-7/PAX breast cancer cells through inhibition of MDR1 activity.
    Choi HS; Cho SG; Kim MK; Lee HJ; Moon SH; Jang HJ; Ko SG
    Mol Cell Biochem; 2017 Feb; 426(1-2):1-8. PubMed ID: 27854072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDR1/P-gp and VEGF synergistically enhance the invasion of Hep-2 cells with multidrug resistance induced by taxol.
    Li L; Jiang AC; Dong P; Wang H; Xu W; Xu C
    Ann Surg Oncol; 2009 May; 16(5):1421-8. PubMed ID: 19247716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides.
    Pan L; Tong Y; Jin Y; Zhou S; Zhang Y; Yang X; Mao N
    Chin Med J (Engl); 2001 Sep; 114(9):929-32. PubMed ID: 11780384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychological stress induces chemoresistance in breast cancer by upregulating mdr1.
    Su F; Ouyang N; Zhu P; Ouyang N; Jia W; Gong C; Ma X; Xu H; Song E
    Biochem Biophys Res Commun; 2005 Apr; 329(3):888-97. PubMed ID: 15752739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor-α directly regulates sensitivity to paclitaxel in neoadjuvant chemotherapy for breast cancer.
    Tokuda E; Seino Y; Arakawa A; Saito M; Kasumi F; Hayashi S; Yamaguchi Y
    Breast Cancer Res Treat; 2012 Jun; 133(2):427-36. PubMed ID: 21909982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cigarette smoke-induced pulmonary inflammatory responses are mediated by EGR-1/GGPPS/MAPK signaling.
    Shen N; Gong T; Wang JD; Meng FL; Qiao L; Yang RL; Xue B; Pan FY; Zhou XJ; Chen HQ; Ning W; Li CJ
    Am J Pathol; 2011 Jan; 178(1):110-8. PubMed ID: 21224049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.